Heise, T., Donnelly, C., Barve, A., & Aubonnet, P. (2019). Pharmacokinetic and pharmacodynamic bioequivalence of proposed biosimilar MYL‐1501D with US and European insulin glargine formulations in patients with type 1 diabetes mellitus. Diabetes Obes Metab.
Citação norma ChicagoHeise, Tim, Charles Donnelly, Abhijit Barve, and Patrick Aubonnet. "Pharmacokinetic and Pharmacodynamic Bioequivalence of Proposed Biosimilar MYL‐1501D With US and European Insulin Glargine Formulations in Patients With Type 1 Diabetes Mellitus." Diabetes Obes Metab 2019.
Citação norma MLAHeise, Tim, Charles Donnelly, Abhijit Barve, and Patrick Aubonnet. "Pharmacokinetic and Pharmacodynamic Bioequivalence of Proposed Biosimilar MYL‐1501D With US and European Insulin Glargine Formulations in Patients With Type 1 Diabetes Mellitus." Diabetes Obes Metab 2019.